Glutathione transferases and development of new principles to overcome drug resistance |
| |
Authors: | Andrea Sau Francesco Valentino Anna Maria Caccuri |
| |
Institution: | a Department of Chemical Sciences and Technologies, University of “Tor Vergata”, Rome, Italy b Department of Internal Medicine, University of “Tor Vergata”, Rome, Italy c Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico “Bambin Gesù”, Rome, Italy |
| |
Abstract: | Chemoresistance is a multifactorial phenomenon and many studies clearly show that a coordinated expression of efflux transporter proteins and phase II conjugating enzymes in tumor cells is linked to the development of the multidrug resistance phenotype. In particular, the overexpression of glutathione S-transferases and efflux pumps in tumors may reduce the reactivity of various anticancer drugs. In recent years it has become evident that glutathione S-transferases are also involved in the control of apoptosis through the inhibition of the JNK signaling pathway. As such, the glutathione S-transferase superfamily has become the focus of extensive pharmaceutical research in attempt to generate more efficient anticancer agents. Here we present an overview of the GST inhibitors and the GST-activated pro-drugs utilized to date to overcome drug resistance. |
| |
Keywords: | GST MDR MAPK Pro-drug Inhibitor |
本文献已被 ScienceDirect 等数据库收录! |
|